Article

COVID-19 OUTCOMES IN MS: EARLY EXPERIENCE FROM NYU MULTIPLE SCLEROSIS COMPREHENSIVE CARE CENTER

2020-05-18

Abstract excerpt

<h4>Objective: </h4> Report outcomes on patients with Multiple Sclerosis (MS) and related disorders with COVID-19 illness. <h4>Methods:</h4> From March 16 to April 30th, 2020, patients with MS or related disorders at NYU Langone MS Comprehensive Care Center (MSCC) were identified with laboratory-confirmed or suspected COVID-19. The diagnosis was established using a standardized questionnaire or by a review of in-p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 421a57c4-4435-5e9c-b7cb-35bf08982f3f
DOI: 10.1101/2020.05.12.20094508

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 OUTCOMES IN MS: EARLY EXPERIENCE FROM NYU MULTIPLE SCLEROSIS COMPREHENSIVE CARE CENTERDOI 10.1101/2020.05.12.20094508Read

Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort StudySemantic proximity Read

COVID-19 in Multiple Sclerosis Patients and Risk Factors for Severe InfectionSemantic proximity Read

COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextSemantic proximity Read

Associations of DMT therapies with COVID-19 severity in multiple sclerosisSemantic proximity Read

COVID-19 in multiple sclerosis patients and risk factors for severe infection.Semantic proximity Read

Disease Modifying Therapies and COVID-19 Severity in Multiple SclerosisSemantic proximity Read

SARS-CoV-2 infection among patients with multiple sclerosis; A cross-sectional studySemantic proximity Read

Increased Rate of Hospitalisation for COVID-19 Amongst Rituximab Treated Multiple Sclerosis Patients: A Study of the Swedish MS RegistrySemantic proximity Read

Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 PandemicSemantic proximity Read

Impact of the first COVID-19 pandemic wave on the Scottish Multiple Sclerosis Register populationSemantic proximity Read

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to OmicronSemantic proximity Read

Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).Semantic proximity Read